Binding of phosphatidylserine-positive microparticles by PBMCs classifies disease severity in COVID-19 patients.

Our patient cohort showed increased percentages of PS + and CD62P + platelets, both markers for platelet activation (Figure 6a–c ), although the increase in CD62P + platelets did not reach statistical significance.

also in 111,027 other papers

Similarly, PS + EV + PBMC, but not PS + dying cells, showed a highly significant correlation with WHO scores (Figure 2c ).

also in 132,142 other papers